Oncoinvent ASA Cash Flow-to-Debt Ratio
Oncoinvent ASA cash flow-to-debt ratio. Oncoinvent ASA (ONCIN) has a Cash Flow-to-Debt Ratio of -3.74x as of June 2025, meaning its operating cash flow of Nkr-73.90 Million could theoretically repay -4% of its total liabilities (Nkr19.75 Million) in one year. See ONCIN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oncoinvent ASA (2021–2025)
Cash flow-to-debt ratio of Oncoinvent ASA from 2021 to 2025. Historical debt coverage capacity for Oncoinvent ASA across 5 annual periods. Also explore net asset growth rate of Oncoinvent ASA to track the company's year-over-year net asset growth rate.
Oncoinvent ASA Cash Flow-to-Debt Ratio by Year (2021–2025)
Oncoinvent ASA cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Oncoinvent ASA. For the full cash flow conversion analysis, see Oncoinvent ASA cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.24x | Nkr-131.19 Million | Nkr58.63 Million | ▲ +8.5% |
| 2024 | -2.44x | Nkr-153.24 Million | Nkr62.68 Million | ▲ +17.1% |
| 2023 | -2.95x | Nkr-138.11 Million | Nkr46.86 Million | ▲ +20.0% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr65.81 Million | — |